C8 MediSensors has received funds from GE Capital and GE Healthcare for its non-invasive glucose monitor.

C8 MediSensors’ non-invasive glucose provides continuous view of their glucose levels without the inconvenience, pain compared to invasive glucose monitoring.

The investment is being made through the GE healthymagination Fund.

GE vice president and GE Healthcare CTO Mike Harsh said this investment aligns with their strategy to fund innovations focused on reducing cost, increasing patient access and improving quality in healthcare.